Eye Care News: Recent News in Eye care
Eye care News Feed
- Almeida highlighted the increasing prevalence of diabetic macular edema and the importance of developing safe, well-tolerated treatments.
- Carl D. Regillo, MD, shares insights on the VERONA trial of EYP-1901 at the Retina World Congress 2025 meeting held in Fort Lauderdale, Florida.
- Discover how dropless cataract surgery enhances patient comfort and outcomes, reducing the need for eye drops and improving recovery efficiency.
- At Retina World Congress 2025, Dilsher S. Dhoot, MD, shares updates on the HELIOS trial and the potential future of tyrosine kinase inhibitors (TKIs)
- Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential impacts on vision and ocular health.
- RWC 2025: Katherine Talcott, MD, discusses the potential connection of auto-immune conditions to AMDThis large database study explored the link between autoimmune problems and AMD.
- In this conversation, Franklin discussed a research study on intraoperative fluorescein angiography in surgical procedures, highlighting significant advancements in surgical visualization and patient outcomes.
- Perfuse Therapeutics reveals promising results for PER-001, a groundbreaking glaucoma treatment, enhancing vision and ocular health in clinical trials.
- Glaucoma management is shifting toward earlier, drop-sparing interventions using sustained drug delivery and advanced laser technologies that improve outcomes and quality of life for both patients and physicians.
- Optigo Biotherapeutics presents promising preclinical data at ARVO.
- Alkeus Pharmaceuticals reveals promising Phase 2 SAGA study results, showing gildeuretinol slows vision decline in geographic atrophy linked to AMD.
- Innovent Biologics initiates phase 2 trial for efdamrofusp alfa, a promising treatment for diabetic macular edema, aiming to improve patient outcomes.
- Beacon Therapeutics reveals promising interim results for laru-zova, a gene therapy showing potential to improve vision in XLRP patients.
- The VAN-2401 phase 1 clinical trial will evaluate the use of KH658 for the treatment of wet AMD.
- Galimedix Therapeutics advances GAL-101, an oral therapy targeting Alzheimer’s and AMD, completing phase 1 SAD study with promising safety results.
- Machine learning algorithms enhance retinopathy of prematurity screening using smartphone images, expanding access in low-resource settings and easing pediatric ophthalmologist workloads.
- Exploring how oral sedation and office-based surgery can enhance efficiency and patient experience
- A one-drop, low dose atropine study assesses accommodative amplitude and dynamics, with clinically applicable findings.
- The extraordinary new handcrafted Strike Collection – launched this month by Kador Eyewear, emerges with strength and style, a tribute to boldness and refinement in the world of eyewear. Here, […] This story Kador Eyewear Launches Strike Sunglasses Collection – appears on The Optical Journal.
- Celebrating the perfect fusion of 70 ’s-inspired boldness and modern craftsmanship, Sunday Somewhere unveils its highly anticipated new optical collection with WestGroupe. The latest release from Sunday Somewhere features a […] This story WestGroupe Unveils Sunday Somewhere Optical Collection – appears on The Optical Journal.
- The Accessories Council (Ac) recently hosted its annual Accessories Council Excellence Awards (ACE Awards) at the iconic Pierre Hotel in New York City. The gala honored and celebrated global brands, […] This story Accessories Council Hosts 2025 ACE Awards – appears on The Optical Journal.
- Allure of Metal is a collection of 11 colorful metal models for women, available in a wide range of styles and sizes. A line designed as a statement of elegance, […] This story J.F. REY – Allure of Metal – appears on The Optical Journal.
- OpticLeague announced the official launch of its new optical wholesale platform, designed to provide a one-stop solution for the global eyewear industry. The platform offers a wide range of products […] This story OpticLeague Launches New Wholesale Platform – appears on The Optical Journal.
- This season, Flexon Eyewear introduces the Motion collection, where bold sleek designs meet performance and functionality. Whether you’re working out or handling daily tasks, the Motion collection is crafted for […] This story Flexon Eyewear Introduces Motion Collection – appears on The Optical Journal.
- Woodys has launched SKINS, a new limited-edition capsule featuring 14 sunglasses that pay tribute to the colors of the skin. This exclusive collection celebrates the beauty of every tone through […] This story Woodys Limited Edition SKINS – appears on The Optical Journal.
- Skans Eyewear is now part of the permanent collection of the British Optical Association Museum, the world’s oldest museum dedicated to the history of vision and eyewear through science, medicine, […] This story Skans Eyewear Goes Into A Museum – appears on The Optical Journal.
- Paloceras, the creative visionary eyewear house, officially lands in the United States with the release of the Pebble Collection. Sculptural. Elevated. Unexpected. Each frame is a bold conversation starter that […] This story Paloceras Debuts in the United States – appears on The Optical Journal.
- This season, Prodesign continues its legacy of blending Danish design DNA with timeless style. Prodesigns’ spring launch introduces frames that balance refinement with bold expression, ensuring every detail is as […] This story Prodesign – Designed To Last. Built To Shine – appears on The Optical Journal.
- Catch up on the top stories in optometry during the week of May 5-May 9.
- At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
- The first-in-class endothelin antagonist intravitreal implant aided in increasing ocular blood flow and improved both visual function and anatomic structure, according to the company.
- The Early Detection of Vision Impairments for Children Act (EDVI), or HR 2527, would allow the federal government to award grants and cooperative agreements to eligible states and communities for children's vision care initiatives.
- Lindsell discusses promising retinal therapeutics, such as at-home therapies, gene therapy, and devices like the Valeda Light Delivery System (LumiThera), which uses photobiomodulation and shows early promise in preventing geographic atrophy altogether.
- Topline results from the MAGNIFY phase 2 clinical trial of oral zervimesine show 28.6% slower geographic atrophy lesion growth compared with placebo.
- Boehringer Ingelheim announced that the phase 2 clinical studies will investigate a potential first-in-class oral compound and a highly specific antibody fragment for geographic atrophy.
- The LuxLife full range of vision IOL is available in a range of cylinders spanning from +0.75D to +6.00D.
- Insurance coverage from the second largest health plan in the US paves the way for expanded access to Luminopia’s unique amblyopia therapeutic.
- When her friend began experiencing dry eye symptoms while undergoing chemotherapy, Katherine Mastrota, OD, MS, FAAO, Dipl ABO, found herself in a unique position to provide specialized advice.
- Topcon Healthcare launches IDHea, an innovative platform enhancing AI research and ocular data access to improve clinical outcomes in health care, alongside Cascader Limited, which was created in partnership with Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology (IoO).
- Shamie encourages taking a contemporary, elevated approach to refractive surgery.
- The recombinant human VEGFR antibody human complement receptor 1 (CR1) fusion protein will be intravitreally administered in up to 150 patients.
- The trial assesses GAL-101 as an oral therapy designed to treat Alzheimer disease, dry age-related macular degeneration, and glaucoma.
- Selina McGee, OD, FAAO, emphasized that today’s approach to presbyopia correction must move beyond traditional methods like spectacles and contact lenses.
- Investigators reported that the benefits of the training for patients with hemianopia, driven by improved blind-side scanning, lasted for more than a month.
Follow us in Facebook
You must be logged in to post a comment.